Pfizer’s clinical data predicted potentially fatal myocarditis in one in every 318 teens. Post-marketing data confirm astronomically high rates of myocarditis injuries. On October 1, 2021, a team of medical researchers and statisticians found that myocarditis rates reported in VAERS were significantly higher in teens than Pfizer had reported in its clinical data. According to the Vaccine Adverse Event Reporting System, there have been 7,537 cases of myocarditis and pericarditis reported following COVID vaccines,85 with 5,602 cases attributed to Pfizer.86 Some 476 of these reports occurred in
...more
